Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors (häftad)
Fler böcker inom
Format
Häftad (Paperback / softback)
Språk
Engelska
Antal sidor
88
Utgivningsdatum
2019-10-05
Förlag
National Academies Press
Dimensioner
226 x 150 x 8 mm
Vikt
159 g
Antal komponenter
1
ISBN
9780309490863

Du kanske gillar

Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors (häftad)

Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors

Proceedings of a Workshop

Häftad Engelska, 2019-10-05
539
  • Skickas inom 7-10 vardagar.
  • Gratis frakt inom Sverige över 159 kr för privatpersoner.
Finns även som
Visa alla 1 format & utgåvor
In recent years, significant progress has been made in the clinical development and use of various types of cancer immunotherapy, all of which rely on the immune system to fight cancer. The majority of new cancer drug applications submitted to the Food and Drug Administration (FDA) are for immunotherapies or combinations involving immunotherapies. One type of immunotherapy is an immune checkpoint inhibitor. Cells in the human body have proteins that regulate the immune system response to foreign invaders (e.g., cancer cells, microorganisms). However, cancer cells can coopt these "checkpoint" proteins and thwart the immune system's ability to recognize and attack cancer cells. To help promote an immune response to cancer, researchers have developed immune checkpoint inhibitors that enable T-cells to recognize cancer cells as foreign and to prevent deactivation of an immune system response. To examine the challenges and opportunities to develop combination cancer therapies that include immune checkpoint inhibitors, the National Cancer Policy Forum held a workshop on July 16?17, 2018, in Washington, DC. This workshop convened stakeholders with a broad range of expertise, including cancer researchers, clinicians, patient advocates, and representatives from industry, academia, and government. This publication summarizes the presentations and discussions from the workshop.
Visa hela texten

Passar bra ihop

  1. Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors
  2. +
  3. Informatics Needs and Challenges in Cancer Research

De som köpt den här boken har ofta också köpt Informatics Needs and Challenges in Cancer Rese... av Institute Of Medicine, Board On Health Care Services, National Cancer Policy Forum, Theresa Wizemann, Sharyl J Nass (häftad).

Köp båda 2 för 928 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »
  • Social Isolation and Loneliness in Older Adults

    Engineering National Academies Of Sciences And Medicine, Division Of Behavioral And Social Sciences And Education, Health And Medicine Division, Cognitive Board On Behavioral And Sensory Sciences, Board On Health Sciences Policy

  • Monitoring Educational Equity

    Engineering National Academies Of Sciences And Medicine, Division Of Behavioral And Social Sciences And Education, Committee On National Statistics, Board On Testing And Assessment, Committee On Developing Indicators Of Educational Equity

  • A Strategic Vision for NSF Investments in Antarctic and Southern Ocean Research

    Engineering National Academies Of Sciences And Medicine, Division On Earth And Life Studies, Polar Research Board, Committee On The Development Of A Strategic Vision For The U S Antarctic Program

  • Quantum Computing

    Engineering National Academies Of Sciences And Medicine, Division On Engineering And Physical Sciences, Intelligence Community Studies Board, Computer Science And Telecommunications Board, Committee On Technical Assessment Of The Feasibility And Implications Of Quantum Computing